Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
10.31
+0.08 (0.78%)
May 18, 2026, 9:47 AM EDT - Market open
Erasca Market Cap
Erasca has a market cap or net worth of $3.21 billion as of May 18, 2026. Its market cap has increased by 659.66% in one year.
Market Cap
3.21B
Enterprise Value
2.82B
1-Year Change
659.66%
Ranking
Category
Stock Price
$10.31
Market Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has increased from $1.86B to $3.21B, an increase of 72.54%. That is a compound annual growth rate of 11.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 3.18B | 201.44% |
| Dec 31, 2025 | 1.06B | 48.72% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
| Jul 16, 2021 | 1.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ACADIA Pharmaceuticals | 3.66B |
| Telix Pharmaceuticals | 3.57B |
| Edgewise Therapeutics | 3.56B |
| Viking Therapeutics | 3.51B |
| Arcus Biosciences | 2.99B |
| Tango Therapeutics | 2.97B |
| Denali Therapeutics | 2.96B |
| Alumis | 2.92B |